Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

Detalles Bibliográficos
Autores principales: Wang, Tiansheng, Lu, Wenchao, Li, Dandan, Tang, Huilin, Yang, Jeff Y., Buse, John B., Stürmer, Til
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118246/
https://www.ncbi.nlm.nih.gov/pubmed/31110120
http://dx.doi.org/10.2337/dc18-1609
_version_ 1783514520891686912
author Wang, Tiansheng
Lu, Wenchao
Li, Dandan
Tang, Huilin
Yang, Jeff Y.
Buse, John B.
Stürmer, Til
author_facet Wang, Tiansheng
Lu, Wenchao
Li, Dandan
Tang, Huilin
Yang, Jeff Y.
Buse, John B.
Stürmer, Til
author_sort Wang, Tiansheng
collection PubMed
description
format Online
Article
Text
id pubmed-7118246
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-71182462020-06-01 Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting Wang, Tiansheng Lu, Wenchao Li, Dandan Tang, Huilin Yang, Jeff Y. Buse, John B. Stürmer, Til Diabetes Care e-Letters: Observations American Diabetes Association 2019-06 2019-05-10 /pmc/articles/PMC7118246/ /pubmed/31110120 http://dx.doi.org/10.2337/dc18-1609 Text en © 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Observations
Wang, Tiansheng
Lu, Wenchao
Li, Dandan
Tang, Huilin
Yang, Jeff Y.
Buse, John B.
Stürmer, Til
Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title_full Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title_fullStr Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title_full_unstemmed Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title_short Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
title_sort assessing the association between dipeptidyl peptidase 4 inhibitor use and inflammatory bowel disease through drug adverse event reporting
topic e-Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118246/
https://www.ncbi.nlm.nih.gov/pubmed/31110120
http://dx.doi.org/10.2337/dc18-1609
work_keys_str_mv AT wangtiansheng assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT luwenchao assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT lidandan assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT tanghuilin assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT yangjeffy assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT busejohnb assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting
AT sturmertil assessingtheassociationbetweendipeptidylpeptidase4inhibitoruseandinflammatoryboweldiseasethroughdrugadverseeventreporting

Ejemplares similares